3De Ponti F, Malagellada JR. Fuctional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management[J]. Phannacol Ther, 1998, 80(1) :49. 被引量：1
4Ozucelik DN.Karaca MA.Sivri B.Effectiveness of pre-emptive metoclopramide infusion in a lleviating pain, discomfort and nausea associated with nasogastric tube insertion: a randomised double - blind, placebocontrolled trial[J]. Int J Clin Pract,2005, 59: 1422. 被引量：1
5Takahashi T, Kurosawa S, Wiley JW, et al. Mechanism for the gastrokinetie action of domperidone. In vitro studies in guinea pigs[J]. Gastroenterology, 1991,101 : 703. 被引量：1
6Bradette M, Pare P, Douville P, et al. Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone[J]. Dig Dis, 1991,36:52. 被引量：1
8Veysey MJ, Malcolm P, Mallet AI, et al. Effects of eisapride on gall-bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial[J]. Gut,2001,49:828. 被引量：1
9Richards RD, Valenzuela GA, Davenport KD, et al. Objective and subjective results of randomized, double - blind, placebo - controlled trial using cisapride to treat gadtroparesis[J]. Dig Dis Sci, 1993, 38(5):811. 被引量：1
10Goldin GF, Marcinkiewicz M, Zbroch T, et al. Esophagoprotective potential of cisapfide. An additional benefit for gastroesophageal reflux disease[J]. Dig Dis Sci,1997, 42(7): 1362. 被引量：1
3Sigala S,Missale G,Missale C,et al.Different neurotransmitter systems are involved in the development of esophageal achalasia[J].Life Sciences,1995,56(16):1 311～1 320. 被引量：1
4Guelrud M,Rossiter A,Souney PF,et al.The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia[J].Gastroenterology,1992,103(2):377～382. 被引量：1
5Jonsson BH,Uvnas-Moberg K,Theorell T,et al.Gastrin cholecy-stokinin and somatostatin in a laboratory experiment of patients with functional dyspepsia[J].Psychosom Med,1998,60(3):331～337. 被引量：1
6Sjolund K,Ekman R,Lindgren S,et al.Disturbed motilin and cholecystokinin release in the irritable bowl syndrome[J].Scand-J-Gastroenterol Bowel,1996,31(11):1 110～1 114. 被引量：1
7Chey WY,Jiu HO,Lee MH,et al.Colonic motility abnormality in patients with irritable bowel synolrome exhibiting abdominal pain and diarrhea[J].Am J Gastroenterology,2001,96(5):1 499～1 506. 被引量：1
8Chen CY,Lu CL,Chang Fy,et al.Endothlin-1 is a candidate Mediating intestinal dysmotility in patients with acute pancreatitis[J].Dig Dis Sci,1999,44:922～926. 被引量：1
9Itoh I, Nakaya M, Suzuki T, et al.Enythromycin mimics exogenous motilin in gastrointestinal contractive activity in the dog.Am J Physiol,1984,247(3):G688 被引量：1
10Pilot MA, Ritchie HD, Thompson H, et al. Alterations in gastrointestinal motilityassociated with Erythromycin. Br J Pharmacol,1984,81(10):1689 被引量：1
